Bautista-Lopez, N., et al., Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine, 2000. 18(14): p. 1393-401 https://www.ncbi.nlm.nih.gov/pubmed/10618537.
Benfield, T., Rämet M., Valentini P., et al. 'Safety, Tolerability, and Immunogenicity of V114 Pneumococcal Vaccine Compared with PCV13 in a 2+1 Regimen in Healthy Infants: A Phase III Study (PNEU-PED-EU-2).' Vaccine, vol. 41, no. 15, Apr. 2023, pp. 2456–65. https://doi.org/10.1016/j.vaccine.2023.02.041.
Beyea SC, Nicoll LH. Administration of medications via the intramuscular route: an integrative review of the literature and research-based protocol for the procedure. Appl Nurs Res. 1995 Feb;8(1):23-33. doi: 10.1016/s0897-1897(95)80279-7. PMID: 7695353.
Bili, A., Dobson S., Quinones J., et al. 'A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Interchangeability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, and PCV13 with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION).' Vaccine, vol. 41, no. 3, Jan. 2023, pp. 657–65. https://doi.org/10.1016/j.vaccine.2022.10.072.
Blyth, C.C., Jayasinghe, S., Andrews R.M. 'A Rationale for Change: An Increase in Invasive Pneumococcal Disease in Fully Vaccinated Children.' Clinical Infectious Diseases, June 2019, p. ciz493. https://doi.org/10.1093/cid/ciz493.
Brown GC, Volk VK, Gottshall RY, Kendrick PL, Anderson HD. Responses of infants to DTP Difterie, Tetanus en Poliomyelitis (Difterie, Tetanus en Poliomyelitis) vaccine used in nine injection schedules. Public Health Rep. 1964;79:585-602.
De Groot, R, T. Oomen, G. Vermeulen, J.A. van Vliet. Handhygiëne in de jeugdgezondheidszorg, ook bij het vaccineren? Infectieziekten Bulletin, maart 2014.
DeSilva M, Vazquez-Benitez G, Nordin JD, Lipkind HS, Klein NP, Cheetham TC, et al., Maternal DTPa-HBV-IPV/Hib vaccine against invasive Haemophilus influenzae type b disease in the Netherlands (2003-16): a case-control study. Lancet Infect Dis. 2018.
Furck Block, S.L., et al., Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Tdap vaccination and risk of infant morbidity. Vaccine. 2017;35(29):3655-60.
Gans, H.A., et al., Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. J Infect Dis, 2013. 207(4): p. 574-82.
Hilgersom JA, AAW Algemene arbeidsongeschiktheidswet (Algemene arbeidsongeschiktheidswet) van Boekel, HC Rümke. 'Aanvallen na vaccinatie van zuigelingen en peuters'. Tijdschr Jeugdgezondheidsz (2017) 49:2–7 DOI 10.1007/s12452-016-0092-4 Januari 2017 https://apps.who.int/iris/bitstream/10665/255353/1/WER9219.pdf.
Lupinacci, R., Rupp R., Wittawatmongkol O., et al. 'A Phase 3, Multicenter, Randomized, Double-Blind, Active-Comparator-Controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4-Dose Regimen of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Healthy Infants (PNEU-PED).' Vaccine, vol. 41, no. 5, Jan. 2023, pp. 1142–52. https://doi.org/10.1016/j.vaccine.2022.12.054.
Macartney, K.K., Chiu, C., Georgousakis, M. et al. Safety of Human Papillomavirus Vaccines: A Review. Drug Saf 36, 393–412 (2013). https://doi.org/10.1007/s40264-013-0039-5.
Markowitz, L.E., et al., Immunization of six-month-old infants with different doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children.
Nicoll LH, Hesby A. Intramuscular injection: an integrative research review and guideline for evidence-based practice. Appl Nurs Res. 2002 Aug;15(3):149-62. doi: 10.1053/apnr.2002.34142. PMID: 12173166.
Puthanakit T., Schwarz T., Esposito S., Frenette L., McNeil S., Rheault P.6 Horn M., Poncelet S., Suryakiran P., Hezareh M., Thomas F., Descamps D., Struyf F. Immune responses to a 2-dose schedule of the HPV-16/18 as04-adjuvanted vaccine in girls (9-14) versus 3 doses in women (1525): a randomised trial Chulalongkorn University, Faculty of Medicine, Department of Pediatrics, Division of Infectious Diseases, Bangkok 2013.
RIVM Rijksinstituut voor Volksgezondheid en Milieu (Rijksinstituut voor Volksgezondheid en Milieu)-notitie: Nynke Rots, Nicoline van der Maas, Hans van Vliet, Laura Antonise-Kamp; Timing van vaccinatie tegen kinkhoest tijdens de zwangerschap. RIVM 3 september 2019.
WHO Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region 2010.
WHO. (2019). 'Hepatitis B vaccines: WHO position paper, July 2017 - Recommendations.' Vaccine 37(2): 223-225.
Vaccinatie van gezonde zwangeren tegen griep. Achtergronddocument bij Griepvaccinatie: herziening van de indicatiestelling 2021, Gezondheidsraad, Nr. 2021/39A/04, 2021.
Duvekot JJH, van de Laar LY, Schreuder I. Vanaf dit najaar griepvaccinatie voor álle zwangeren [Influenza vaccination from this autumn for all pregnant women: less influenza infections among neonates and pregnant women]. Ned Tijdschr Geneeskd. 2023;167:D7850.
Foo DYP, Sarna M, Pereira G. Early Childhood Health Outcomes Following In Utero Exposure to Influenza Vaccines: A Systematic Review.Pediatrics. 2020-08-01;146(2).
Geersing TH, Hilgersom WJA, Tempels-Pavlica Ž, Rümke HC, de Koning LCMJ, Borgsteede SD. Overgevoeligheidsreacties en vaccins [Hypersensitivity reactions and vaccines]. Ned Tijdschr Geneeskd. 2017;161:D1491.
Madhi SA, Cutland CL, Kuwanda L, Weinberg A, Hugo A, Jones S, et al. Influenza vaccination of pregnant women and protection of their infants.N Engl J Med 2014; 371(10): 918-931.
Nunes MC, Madhi SA. Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: A systematic review and meta-analysis.Hum Vaccin Immunother 2018; 14(3): 758-766.
Omer SB, Clark DR, Madhi SA, Tapia MD, Nunes MC, Cutland CL, et al. Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials.Lancet Respir Med 2020; 8(6): 597-608.
Steinhoff MC, Katz J, Englund JA, Khatry SK, Shrestha L, Kuypers J, et al. Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial.Lancet Infect Dis 2017; 17(9): 981-989.
Tapia MD, Sow SO, Tamboura B, Teguete I, Pasetti MF, Kodio M, et al. Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, activecontrolled, observer-blind, randomised phase 4 trial.Lancet Infect Dis 2016; 16(9): 1026-1035.
